Conference Schedule

Speaker:

In an era where AI-powered, omnichannel strategies are transforming the healthcare landscape, HCP engagement is evolving to address critical patient care gaps. From delivering personalized educational content to optimizing engagement across channels, these innovations are setting new standards. What does this mean for the future of medical affairs, and how can these strategies drive measurable impact?

  • Learn how healthcare professionals interact with digital platforms and how to tailor strategies to meet their needs.
  • Explore how AI-powered tools can deliver targeted content that drives deeper engagement.
  • Discover best practices for combining multiple engagement channels to maximize impact and effectively close patient care gaps.
Speakers:

Implementing new AI models and large language models can enhance data collection and accelerate data output, ultimately influencing your impact assessments. How is your team evaluating the impact of this data? What tools or methods are you using to measure it? Additionally, what baseline metrics are you relying on for comparison?

  • Understand how digitalization has offered new ways to interpret data
  • Look at different ways to measure the impact
  • Go over concerns such as data privacy

In this new era of increased digitalization, patients now have the ability to access their health data like never before. Wearable devices, genetic testing, and electronic health records are just some examples of increased patient autonomy in healthcare. How will this improve patient engagement and self-care in the long term?

  • Analyze how enhancing the patient voice and autonomy will lead to better health outcomes
  • Understand the importance of digital methods of data collection, but also be aware of data privacy challenges
Speakers:

Artificial intelligence is continually transforming the landscape of medical affairs. How will AI be utilized in 2025 across medical strategy, field medical, medical education, and literature? How can AI redefine medical affairs, driving innovation in patient outcomes and amplifying strategic impact?

  • Understand the latest advancements in AI specific to medical affairs
  • Examine real use cases of AI applications across different facets of medical affairs
  • Envision the future of AI in medical affairs by evaluating its potential long-term effects on patient engagement
Speaker:

Pre-commercial Pharma and Biotech budgets and timelines are continually diminishing. This in combination with uncertainties on product approvals and HR pressures, hiring the right medical person and team is critical. Solo and small medical teams quickly become overburdened in current models. Discover the transformative advantages of adopting a fractional medical affairs team for pre-commercial assets and hear case studies on how a fractional team in combination with AI powered tools have dramatically improved efficiencies and success rates in pre- commercial programs

  • Highlight the operational vulnerabilities, knowledge gaps, and burnout risks inherent in relying on solo medical representatives in traditional small pharma models.
  • Showcase how fractional teams bring diverse expertise, scalability, and greater alignment with cross-functional needs to drive better outcomes.
  • Explore how AI-powered tools enhance team productivity, streamline data analysis, and optimize strategic decision-making for teams of all sizes with real world examples.
Speaker:

Medical Affairs teams are very relationship-focused, but how many interactions should be non-personal/digital and how many should be face to face? In a study conducted by AJMC, it was found that 55% of patients prefer digital healthcare methods vs in-person methods. Based on how quickly we are moving towards digital platforms, how can your teams find a balance between the two?

  • Address how medical affairs teams should collaborate to meet their needs
  • Discuss the balance between digital and in-person platforms
  • Plan your digital publication strategy
  • Learn how AI can assist in supporting these engagements
Speakers:

The global AI healthcare market is projected to reach $31.3 billion by 2025. However, implementing AI models within your organization can be complex, with challenges such as change management and limited understanding of the technology. Is your team equipped to evaluate, comprehend, and successfully integrate AI into your company's operations?

  • Discuss the challenges associated with change management
  • Create a plan to better understand the function of each AI model
  • Look at how misunderstanding an AI model’s limitations can lead to incorrect data and outputs
Speaker:

A solid medical affairs strategy must be translated into an impactful scientific narrative supported by digital-ready content. Today medical content is available to feed omnichannel approaches across all available medical channels. However, the incorporation of affiliate input and country adoption of globally created materials significantly influences their impact and reach.

  • Understand examples of medical enhance clinical data materials and different organizational structure approaches
  • Discuss what modular content means in this context and the role it plays
  • Debate the challenges of implementing a global to local medical content strategy into your company
Speakers:

Due to advancements in digital technologies, the healthcare sector is undergoing rapid transformation, which in turn affects how medical affairs teams operate and engage with both internal and external stakeholders. How can your team create a positive environment focused on employee experience, digital-first mindsets, and change management?

  • Explain how to ensure a digital-first mindset and thinking
  • Embrace new digital methods to connect with stakeholders and enhance patient care
  • Navigate the digital shift effectively
Speakers:

Day One Concludes

Speaker:

Medical affairs teams must move to communicating via digital channels to meet the needs of their target audience. How can leveraging social media and engaging with digital thought leaders enhance your patient outreach strategy?

  • Expand on the prevalence and rise of social media in healthcare (nephrology specifically)
  • Explore which digital channel is right for you
  • Leverage social media to help you reach your target audience
  • Explain the role of DOLs and how you can partner with them
Speakers:

Digital innovation and AI-driven tools are transforming the way we interact with HCPs. Solution offerings such as an MSL Live Assist feature and a GenAI scientific chatbot, can enhance HCP experience, accelerate scientific exchange, and ultimately result in better patient care. Is your team prepared to improve HCP experiences and set new standards for engagement within the medical field?

  • Understand the role of digital and AI technologies in interacting with HCPs
  • Discover how an “MSL Live Assist” feature offers HCPs immediate access to Medical Affairs expertise and supports their specific needs
  • Discover how a “GenAI chatbot tool” enables MSLs to swiftly respond to unsolicited questions from healthcare providers; and faciliates a science and data based approach in the field
  • Explore strategies for building a unified platform that consolidates HCP needs to enhance the overall digital experience
Speakers:

Large pharmaceutical companies have high enough revenue to invest in advanced research, but where smaller companies may lack in funding they are open culturally quicker to enact change. What are the main differences when curating a digital strategy plan between small vs. large pharmaceutical companies?

  • Define the differences between large and small pharma
  • Examine the challenges and benefits associated with each different company
  • Build a curated digital roadmap for both small and large pharma
Speakers:

The AI healthcare market is expected to grow at a compound annual growth rate of 40.2% from 2022 to 2029. To build a better plan for utilizing AI processes, you must clearly evaluate your company’s capacity, logistics, and budget.

  • Determine where your company is in terms of budget
  • Review the importance of being prepared to utilize AI in your company
  • Develop the most effective plan for your team
Speaker:

In 2022, the global market for healthcare interoperability solutions was valued at approximately $3.4 billion and is projected to grow at a rate of 12.9% through 2027. Interoperability is crucial for improving patient care and facilitating efficient data exchange. However, challenges such as data privacy concerns, technological barriers, and fragmented healthcare systems are emerging.

  • Explain the advantages of interoperability
  • Dissect the challenges that data privacy concerns bring up
  • Build a plan to ensure interoperability in your company
Speaker:

Artificial Intelligence has been used to increase efficiency for MSLs in many ways, one of these is by determining how to reach KOLs through different communication methods. How can your team generate insights from MSL-collected data using AI? Can your team determine in what ways AI is influencing the future of MSL efficiency?

  • Define the importance of MSLs and how digitalization is affecting them
  • Determine how AI can help MSLs monitor patient data in real-time
  • Focus on processing insights data from MSLs using AI technology
Speakers:

Regulatory approval can often be a lengthy process, and in some cases, approval might not be granted at all. Are there ways to leverage innovations that haven't yet received regulatory clearance? Why are approvals being delayed, and what steps can be taken to address these challenges and expedite the process?

  • Consider what digital health can do outside of regulatory approval
  • Understand what hurdles have to be overcome to receive regulatory approval
Speaker:

Now that we are entering 2025, relying solely on face-to-face communications with HCPs is no longer an option. Just as HCPs have shifted to providing digital services like telehealth, pharmaceutical companies should also prioritize digital engagement strategies. 84% of HCPs have expressed an interest in maintaining and increasing virtual interactions with patients. How can your team build a digital strategy to engage HCPs and meet them where they are?

  • Discover ways that pharmaceutical companies can engage HCPs
  • Learn about challenges that are associated with HCP engagement
  • Explain the different options for HCP engagement platforms and which are best
Speaker:

Conference Concludes

 

 

 

 

 

 

 

I Accept